ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D…

Overview of attention for article published in BMC Cancer, May 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 66 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 23,946 followers.

ICECREAM:randomised phase II study cetuximab alone or in combination with irinotecan https://t.co/8qu0JHbqCf #hvhebron #onco [Text complet]

Reply Repost Favourite

Best clinical trial names of the week: ICECREAM https://t.co/5NBlyhzY6Q and SENORITA https://t.co/w1xy1L8aEu from BMC #Cancer

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.